Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Hybrid Imaging Market, by Application
1.4.2 Europe Hybrid Imaging Market, by Type
1.4.3 Europe Hybrid Imaging Market, by End User
1.4.4 Europe Hybrid Imaging Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2019-Dec – 2015-Jan) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2019-Dec – 2015-Jun) Leading Players
Chapter 4. Europe Hybrid Imaging Market by Application
4.1 Europe Oncology Market by Country
4.2 Europe Ophthalmology Market by Country
4.3 Europe Cardiology Market by Country
4.4 Europe Brain & Neurology Market by Country
4.5 Europe Other Applications Market by Country
Chapter 5. Europe Hybrid Imaging Market by Type
5.1 Europe PET/CT systems Market by Country
5.2 Europe SPET/CT systems Market by Country
5.3 Europe PET/MR systems Market by Country
5.4 Europe OCT/Fundus Imaging System Market by Country
5.5 Europe Other Types Market by Country
Chapter 6. Europe Hybrid Imaging Market by End Use
6.1 Europe Hospitals Market by Country
6.2 Europe Diagnostic Imaging Centers Market by Country
6.3 Europe Other End Use Market by Country
Chapter 7. Europe Hybrid Imaging Market by Country
7.1 Germany Hybrid Imaging Market
7.1.1 Germany Hybrid Imaging Market by Application
7.1.2 Germany Hybrid Imaging Market by Type
7.1.3 Germany Hybrid Imaging Market by End Use
7.2 UK Hybrid Imaging Market
7.2.1 UK Hybrid Imaging Market by Application
7.2.2 UK Hybrid Imaging Market by Type
7.2.3 UK Hybrid Imaging Market by End Use
7.3 France Hybrid Imaging Market
7.3.1 France Hybrid Imaging Market by Application
7.3.2 France Hybrid Imaging Market by Type
7.3.3 France Hybrid Imaging Market by End Use
7.4 Russia Hybrid Imaging Market
7.4.1 Russia Hybrid Imaging Market by Application
7.4.2 Russia Hybrid Imaging Market by Type
7.4.3 Russia Hybrid Imaging Market by End Use
7.5 Spain Hybrid Imaging Market
7.5.1 Spain Hybrid Imaging Market by Application
7.5.2 Spain Hybrid Imaging Market by Type
7.5.3 Spain Hybrid Imaging Market by End Use
7.6 Italy Hybrid Imaging Market
7.6.1 Italy Hybrid Imaging Market by Application
7.6.2 Italy Hybrid Imaging Market by Type
7.6.3 Italy Hybrid Imaging Market by End Use
7.7 Rest of Europe Hybrid Imaging Market
7.7.1 Rest of Europe Hybrid Imaging Market by Application
7.7.2 Rest of Europe Hybrid Imaging Market by Type
7.7.3 Rest of Europe Hybrid Imaging Market by End Use
Chapter 8. Company Profiles
8.1 Siemens AG (Siemens Healthineers)
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Segmental and Regional Analysis
8.1.3 Research & Development Expense
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations, and Agreements:
8.1.4.2 Product Launches and Product Expansions:
8.1.5 SWOT Analysis
8.2 Canon, Inc. (Canon Medical Systems Corporation)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.5.3 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 General Electric (GE) Co. (GE Healthcare)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Hitachi, Ltd. (Hitachi Healthcare)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expense
8.7 Bruker Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Acquisition and Mergers:
8.8 Atlantis Worldwide, LLC
8.8.1 Company Overview
8.9 Cubersa, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Product Launches and Product Expansions:
8.1 Amber Diagnostics, Inc.
8.10.1 Company Overview
Unique Offerings 
